Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Clinical Oncology

• Publication date

  1998-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1200/JCO.1998.16.7.2478PMID 9667267
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic implications of chromosome 17p deletions in human medulloblastomas

  2005cited by this paper
• High‐resolution deletion mapping of chromosome arm 17p in childhood primitive neuroectodermal tumors reveals a common chromosomal disruption within the Smith‐Magenis region, an unstable region in chromosome band 17p11.2

  1997cited by this paper
• DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3–26.1 is deleted in malignant brain tumours

  1997cited by this paper
• Ordering of 66 STSs along the entire short arm of human chromosome 17 and chromosome assignment of a transcribed sequence (FMR1L2) homologous to FMR1.

  1996cited by this paper
• Human Homolog of patched, a Candidate Gene for the Basal Cell Nevus Syndrome

  1996cited by this paper
• High dose chemotherapy with autologous stem cell rescue for patients with medulloblastoma

  1996cited by this paper
• Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome.

  1996cited by this paper
• Correlation of chromosome 17p loss with clinical outcome in medulloblastoma.

  1996cited by this paper
• Mapping of chromosomal gains and losses in primitive neuroectodermal tumors by comparative genomic hybridization

  1996cited by this paper
• Microsatellite analysis of childhood brain tumors

  1996cited by this paper
• High-dose melphalan and cyclophosphamide with autologous bone marrow rescue for recurrent/progressive malignant brain tumors in children: a pilot pediatric oncology group study.

  1996cited by this paper
• Loss of heterozygosity at locus F13B on chromosome 1q in human medulloblastoma

  1996cited by this paper
• Deregulated expression of PAX5 in medulloblastoma.

  1995cited by this paper
• Microsatellite analysis of loss of heterozygosity on chromosomes 9q, 11 p and 17p in medulloblastomas

  1994cited by this paper
• Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma.

  1994cited by this paper
• Chromosome analysis of brain tumors in childhood

  1994cited by this paper
• Detection of trisomy 8 on blood smears using fluorescence in situ hybridization.

  1993cited by this paper
• Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors.

  1993cited by this paper
• Cytogenetic analysis of 109 pediatric central nervous system tumors.

  1993cited by this paper
• A tetranucleotide repeat for the F13B locus.

  1992cited by this paper
• Rapid physical mapping of cloned DNA on banded mouse chromosomes by fluorescence in situ hybridization.

  1992cited by this paper
• Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb.

  1992cited by this paper
• Medulloblastomas and related primitive neuroectodermal brain tumors of childhood recapitulate molecular milestones in the maturation of neuroblasts.

  1992cited by this paper
• Chromosome 11p15 deletions in human malignant astrocytomas and primitive neuroectodermal tumors.

  1992cited by this paper
• Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis.

  1992cited by this paper
• Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors.

  1992cited by this paper
• Prognostic significance of molecular genetic markers in childhood brain tumors.

  1991cited by this paper
• Loss of heterozygosity on 6q, 16q, and 17p in human central nervous system primitive neuroectodermal tumors.

  1991cited by this paper
• N-MYC and C-MYC Oncogenes Amplification in Medulloblastomas. Evidence of Particularly Aggressive Behavior of a Tumor with C-MYC Amplification

  1991cited by this paper
• Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts.

  1990cited by this paper
• Cytogenetics and Molecular Genetics of Malignant Gliomas and Medulloblastoma

  1990cited by this paper
• Reduction to homozygosity and gene amplification in central nervous system primitive neuroectodermal tumors of childhood.

  1990cited by this paper
• High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones.

  1990cited by this paper
• A simple salting out procedure for extracting DNA from human nucleated cells.

  1988cited by this paper
• Survival of children with brain tumors

  1986cited by this paper
• A classification system for primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa

  1985cited by this paper

• Differential regulation of Shh-Gli1 cell signalling pathway on homeodomain transcription factors Nkx2.2 and Pax6 during the medulloblastoma genesis

  2024cites this paper
• Clinicopathological Characteristics of non-WNT/non-SHH Medulloblastoma Cases in a Pediatric Egyptian Cohort

  2023cites this paper
• Cancer of the Central Nervous System

  2020cites this paper
• Tumoren des Gehirns und des Spinalkanals

  2020cites this paper
• Loss of Heterozygosity (LOH) at 17p13 and 22q13 are Shared by Breast and Thyroid Carcinomas for Metastasis

  2019cites this paper
• Modern Principles of CNS Tumor Classification

  2018cites this paper
• ATM in breast and brain tumors: a comprehensive review

  2018cites this paper
• Estudio molecular en meduloblastomas pediátricos: determinación y validación de marcadores genéticos para la estratificación del tratamiento adaptado a factores de riesgo clínico y biológico

  2017cites this paper
• Suprasellar Primitive Neuroectodermal Tumor in an Adult.

  2016cites this paper
• Medulloblastoma and CNS Primitive Neuroectodermal Tumors

  2015cites this paper
• Practical molecular pathology and histopathology of embryonal tumors.

  2015cites this paper
• Cytogenetic prognostication within medulloblastoma subgroups.

  2014cites this paper
• Mutation and expression analysis in medulloblastoma yields prognostic variants and a putative mechanism of disease for i17q tumors

  2014cites this paper
• BMI1-BMP Connection in Medulloblastoma Pathogenesis

  2014cites this paper
• Chromosomal Analysis: Clinical Applicability to Brain Cancers

  2013cites this paper
• Central nervous system tumors.

  2013cites this paper
• Examens cytologique, histologique, immunohistochimique et génétique des tumeurs du système nerveux central

  2013cites this paper
• Medulloblastoma: recurrence and metastasis.

  2013cites this paper
• Impact of genetic targets on primary brain tumor therapy: what's ready for prime time?

  2013cites this paper
• Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: A report from the Children's Oncology Group

  2013cites this paper
• Survival for Medulloblastoma Revealed STK15 as Independent Predictor Microarray-Based Screening for Molecular Markers in

  2013cites this paper
• MicroRNAs in Medulloblastoma

  2013cites this paper
• Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement.

  2012cites this paper
• Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma.

  2012cites this paper
• The molecular basis for central nervous system primitive neuroectodermal tumour development

  2012cites this paper
• Distinct patterns of human medulloblastoma dissemination in the developing chick embryo nervous system

  2012cites this paper
• Cytogenetics in pediatric medulloblastomas

  2012cites this paper
• Retroviral oncogenes: a historical primer

  2012cites this paper
• WIP1 Enhances Tumor Formation in a Sonic Hedgehog–Dependent Model of Medulloblastoma

  2012influential citation
• Supratentorial Primitive Neuroectodermal Tumors of the Central Nervous System in Adults: Molecular and Histopathologic Analysis of 12 Cases

  2011cites this paper
• c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients

  2011cites this paper
• Identification of c-myc-dependent proteins in the medulloblastoma cell line D425Med

  2011cites this paper
• Response of medulloblastoma cells to vincristine and lomustine: role of TRKC, CTNNB1 and STK15.

  2011cites this paper
• Hedgehogs, flies, Wnts and MYCs: the time has come for many things in medulloblastoma.

  2011cites this paper
• Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma

  2011cites this paper
• The Potential Role of Environmental Exposures and Genomic Signaling in Development of Central Nervous System Tumors

  2011cites this paper
• Molecular Diagnostics in Embryonal Brain Tumors

  2011cites this paper
• [Medulloblastomas: review].

  2011cites this paper
• FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma.

  2011cites this paper
• Disabling c-Myc in Childhood Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor Cells by the Potent G-Quadruplex Interactive Agent S2T1-6OTD

  2010cites this paper
• Molecular diagnostics of CNS embryonal tumors

  2010cites this paper
• Large cell/anaplastic medulloblastoma: Outcome according to myc status, histopathological, and clinical risk factors

  2010cites this paper
• High‐risk medulloblastoma: Does c‐myc amplification overrule histopathology?

  2010cites this paper
• Central Nervous System Primitive Neuroectodermal Tumors: A Clinicopathologic and Genetic Study of 33 Cases

  2010cites this paper
• Childhood Medulloblastoma

  2010cites this paper
• Correlation of tumour volume of childhood posterior fossa tumours with outcome

  2010cites this paper
• Genetics of medulloblastoma: clues for novel therapies

  2010cites this paper
• Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma.

  2010cites this paper
• Medulloblastoma : cell of origin & hereditary cancer syndromes

  2010cites this paper
• Novel oncogene amplifications in tumors from a family with Li–Fraumeni syndrome

  2009cites this paper
• Targeting Myc in pediatric malignancies of the central and peripheral nervous system.

  2009cites this paper
• Curcumin inhibits the Sonic Hedgehog signaling pathway and triggers apoptosis in medulloblastoma cells

  2009cites this paper
• Molecular genetic analysis of a primitive neuroectodermal tumor arising after intracranial radiation and chemotherapy for leukemia.

  2009cites this paper
• Medulloblastomas: a correlative study of MIB-1 proliferation index along with expression of c-Myc, ERBB2, and anti-apoptotic proteins along with histological typing and clinical outcome

  2009cites this paper
• Cytogenetic and histopathologic studies of congenital supratentorial primitive neuroectodermal tumors: A case report

  2009cites this paper
• Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci.

  2009cites this paper
• Medulloblastoma: what is the role of molecular genetics?

  2008cites this paper
• NÁDORY CENTRÁLNÍHO NERVOVÉHO SYSTÉMU U DĚTÍ A MLADISTVÝCH

  2008cites this paper
• The origins of medulloblastoma subtypes.

  2008cites this paper
• Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells.

  2008cites this paper
• Accumulation of genomic aberrations during clinical progression of medulloblastoma

  2008cites this paper
• Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas.

  2008cites this paper
• Die Rolle des Presenilin 1 Gens in embryonalen Tumoren

  2008cites this paper
• Paratesticular metastases from a medulloblastoma

  2008cites this paper
• Medulloblastoma, Primitive Neuroectodermal Tumors, and Pineal Tumors

  2008cites this paper
• Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells

  2007cites this paper
• Molecular pathogenesis of adult brain tumors and the role of stem cells.

  2007cites this paper
• Prognostic Relevance of Clinical and Biological Risk Factors in Childhood Medulloblastoma: Results of Patients Treated in the Prospective Multicenter Trial HIT'91

  2007cites this paper
• Genome Wide Copy Number Abnormalities in Pediatric Medulloblastomas as Assessed by Array Comparative Genome Hybridization

  2007cites this paper
• Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma.

  2007cites this paper
• Ophthalmic

  2007cites this paper
• Which Clinical and Biological Tumor Markers Proved Predictive in the Prospective Multicenter Trial HIT’91 - Implications for Investigating Childhood Medulloblastoma

  2007cites this paper
• Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification

  2007cites this paper
• Geneticc alterations in childhood medulloblastomaa analyzed by Comparativee Genomic Hybridizatio n

  2007cites this paper
• Outcome in children with brain tumours diagnosed in the first year of life: long-term complications and quality of life

  2007cites this paper
• Detection of genetic and chromosomal aberrations in medulloblastomas and primitive neuroectodermal tumors with DNA microarrays

  2006cites this paper
• Identification and Analysis of Tumor Suppressor Loci at Chromosome 10q23.3-10q25.3 in Medulloblastoma

  2006cites this paper
• Screening molekularbiologischer Marker zur Risikostratifizierung bei Medulloblastomen

  2006cites this paper
• Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood

  2006cites this paper
• [Risk stratification in medulloblastoma: screening for molecular markers].

  2006cites this paper
• Advances in treatment of pediatric brain tumors

  2006cites this paper
• c-Myc downregulation: a critical molecular event in resveratrol-induced cell cycle arrest and apoptosis of human medulloblastoma cells

  2006cites this paper
• Medulloblastomas: new directions in risk stratification.

  2006cites this paper
• Molecular biology and genetic models of glioma and medulloblastoma

  2006cites this paper
• Isochromosome breakpoints on 17p in medulloblastoma are flanked by different classes of DNA sequence repeats

  2006cites this paper
• Chapter 5 - Microarray Analysis and Proteomic Approaches to Drug Development

  2006cites this paper
• Recent advances in embryonal tumours of the central nervous system

  2005influential citation
• CYP1A1 and CYP1B1 expressions in medulloblastoma cells are AhR-independent and have no direct link with resveratrol-induced differentiation and apoptosis.

  2005cites this paper
• Genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumours of the central nervous system

  2005cites this paper
• Diagnosis and Medulloblastoma : Clinical and biologic aspects

  2005cites this paper
• [Supratentorial primitive neuroectodermal tumor: a single center experience and comparison with the literature].

  2005cites this paper
• Examens cytologique, histologique, immunohistochimique et génétique des tumeurs du système nerveux central

  2005cites this paper
• Molecular Diagnostics in Central Nervous System Tumors

  2005cites this paper
• Biology and therapy of malignant solid tumors in childhood.

  2005cites this paper
• Cytogenetics and molecular genetics of childhood brain tumors 1

  2005influential citation
• Biologic risk stratification of medulloblastoma: the real time is now.

  2004cites this paper
• Current approaches to CNS tumors in infants and very young children

  2004cites this paper
• Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization.

  2004cites this paper
• Molecular abnormalities in pediatric embryonal brain tumors--analysis of loss of heterozygosity on chromosomes 1, 5, 9, 10, 11, 16, 17 and 22.

  2004cites this paper
• Imatinib mesylate (STI571) interference with growth of neuroectodermal tumour cell lines does not critically involve c-Kit inhibition.

  2004cites this paper